News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Clinical - Post-Approval (Research/Post Marketing/Phase IV)
Eisai Inc. (ESALF.PK) Release: Meta-Analysis Of Published Trials Supports The Extrapolation Of Antiepileptic Drug Efficacy Data From Adult To Pediatric Patients With Primary Generalized Tonic-Clonic Seizures 4/27/2017
Britannia Pharmaceuticals Limited: Landmark Apomorphine Study Confirms Its Established Role As A Highly Effective Treatment For Parkinson's Disease Patients Whose Symptoms Cannot Be Controlled On Standard Therapies 4/26/2017
Catabasis (CATB) Announces Favorable Results For Functional Assessments In The Movedmd Trial For Edasalonexent In Duchenne Muscular Dystrophy At American Academy of Neurology 69th Annual Meeting 4/25/2017
Cartiva Announces Completion Of Patient Enrollment And Treatment In Study Of Cartiva Synthetic Cartilage Implant For Pain Associated With Osteoarthritis Of The Thumb 4/25/2017
Paragonix Technologies Inc. Announces Presentation Of The Sherpapak Organ Transport Systems At American Transplant Congress (Chicago, April 29 - May 3, 2017) 4/24/2017
Biogen (BIIB)’s SPINRAZA (Nusinersen) Receives Positive CHMP Opinion For The Treatment Of Spinal Muscular Atrophy 4/24/2017
Novartis AG (NVS) Real-World Data At Aan Confirms Benefit Of Gilenya On Four Key Measures Of Disease Activity In Relapsing MS 4/24/2017
Real-World Observational Study In The U.S. Veterans Affairs System Evaluating Use Of Merck & Co. (MRK)’s ZEPATIER (Elbasvir And Grazoprevir) Shows High Sustained Virologic Response Rates In Patients With Chronic Hepatitis C 4/21/2017
Thermo Fisher Scientific (TMO) Release: Multi-Center Clinical Study Confirms Decreased Levels Of Procalcitonin As An Independent Predictor Of Mortality In Patients With Severe Sepsis And Septic Shock 4/20/2017
NIH Study In The New England Journal of Medicine Shows Novartis AG (NVS) Drug Eltrombopag As First-Line Therapy With Standard Treatment Improves Responses In Severe Aplastic Anemia 4/20/2017
Relypsa (RLYP) Presents Veltassa Phase IV Data Showing Consistent Efficacy And Safety Whether Taken With Or Without Food In Patients With Hyperkalemia 4/20/2017
Kowa Pharmaceuticals America Announces INTREPID Trial Results In The Lancet HIV Showing Superior LDL Cholesterol Reduction With LIVALO (Pitavastatin) Compared With Pravastatin In Adults With HIV And Dyslipidemia 4/19/2017
Egalet Announces FDA Acceptance Of File For Prior Approval Supplement For OXAYDO (Oxycodone Hcl, USP) Tablets C-II 10 Mg And 15 Mg Dosage Strengths 4/18/2017
The Center For The Biology Of Chronic Disease Release: Gene-Eden-VIR/Novirin Vs. Antiviral Drugs, CBCD Reports High Interest In The Comparison Between Natural Treatments And Approved Drugs 4/17/2017
SCIENCE CHINA Life Sciences English Edition Publishes Domestic Type 2 Diabetes Research Findings 4/12/2017
More Than 30 Presentations Of New Investigational Data From Sanofi Genzyme (SNY)’s Multiple Sclerosis Franchise To Be Featured AtAAN 4/11/2017
Galderma Laboratories Presents Results From Phase IV Clinical Studies Of Restylane Refyne And Restylane Defyne At The 15th Aesthetic & Anti-Aging Medicine Annual World Congress 4/7/2017
Switching To Sanofi (SNY)'s Toujeo Showed Significant Reductions In Blood Sugar And Significantly Lower Incidence Of Hypoglycemia In A Real-World Observational Study 4/3/2017
Aequus Pharmaceuticals Announces Positive Results From Second Proof Of Concept Study For Long-Acting Aripiprazole Transdermal Patch 4/3/2017
Cumberland Pharmaceuticals (CPIX) Release: Caldolor Demonstrates Significant Post Surgical Pain Reduction And Decrease In Opioid Use 3/28/2017
AstraZeneca PLC (AZN) Release: New Data Demonstrate RSV Immunoprophylaxis With SYNAGIS (Palivizumab) May Result In Reduced Overall Costs In Preterm Infants Born At 29-32 wGA Who Are Less Than Three Months Of Age 3/28/2017
eClinicalHealth Celebrates 5 Years In Business Supporting Direct-to-Patient Research Models For Clinical Trials 3/27/2017
EMA’s CHMP Recommends Approval Of Merck & Co. (MRK)’s KEYTRUDA (Pembrolizumab) For The Treatment Of Patients With Relapsed Or Refractory Classical Hodgkin Lymphoma 3/24/2017
Pfizer (PFE) Receives Positive CHMP Opinion For TRUMENBA For Prevention Of Meningococcal Group B Disease 3/24/2017
UCSF Heart Doctor Wary of Amgen (AMGN)-Paid Repatha Study 3/23/2017
Horizon Pharma (HZNP) To Present Data On RAVICTI (Glycerol Phenylbutyrate) Oral Liquid For Urea Cycle Disorder Patients Aged Two Months To Two Years 3/22/2017
Prime Therapeutics Study Finds 97 Percent Of Hepatitis C Patients Cured With Harvoni Treatment 3/21/2017
New Analysis Shows Novartis AG (NVS) Entresto Improves Glycemic Control In Reduced Ejection Fraction Heart Failure Patients With Diabetes 3/20/2017
Boehringer Ingelheim Release: Uninterrupted Pradaxa (Dabigatran Etexilate Mesylate) Showed Less Major Bleeding Than Warfarin In Atrial Fibrillation Patients Undergoing Catheter Ablation 3/20/2017
AstraZeneca PLC (AZN)'s Diabetes Med Cuts Death Rates in Real-World Trial 3/20/2017
Disappointment Hits as Amgen (AMGN)'s Repatha Prevents Heart Attacks, But Not Deaths 3/20/2017
Oncolytics Biotech Inc. (ONC.TO) Enters Into First-In-Class Collaboration With Myeloma UK And Celgene (CELG) Using REOLYSIN In Combination With Imnovid Or Revlimid In Patients With Myeloma 3/16/2017
Horphag Release: Study Shows Pycnogenol Normalizes Cardiovascular Risk Factors In Perimenopausal Women 3/16/2017
Amgen (AMGN) Release: Repatha (Evolocumab) Four-Year Open-Label Follow-Up Study Published In 'JAMA Cardiology' 3/15/2017
Data From BioTime (BTX)’s Opregen Trial In Dry-AMD To Be Presented At Association for Research in Vision & Ophthalmology On May 8 3/15/2017
Elite Pharma (ELI) Initiates Pivotal Bioequivalence Fed Study For Reformulated SequestOx 3/13/2017
Investors Anxiously Await for Amgen (AMGN)'s 27,500-Patient Heart Trial Data This Week 3/13/2017
The OHSU Knight Cancer Institute Release: "The New England Journal of Medicine" Publishes Long-Term Results Of Gleevec® For Patients With Chronic Myeloid Leukemia 3/9/2017
New Head-To-Head Data Shows Significantly Higher Response Rates For Eli Lilly (LLY) 's Taltz (Ixekizumab) Compared To Stelara (Ustekinumab) In Patients With Moderate-To-Severe Plaque Psoriasis 3/6/2017
Celgene (CELG) Release: Oral OTEZLA (Apremilast) Demonstrated Significant Improvement Versus Placebo In Trial Of Patients With Moderate Plaque Psoriasis Who Were Naïve To Systemic And Biologic Therapy 3/6/2017
New Data Demonstrate Sandoz Proposed Biosimilar Adalimumab Has Equivalent Efficacy To Reference Medicine 3/6/2017
Novartis AG (NVS)' Cosentyx Shows Almost All Psoriasis Patients Rapidly Regain Skin Clearance Following A Treatment Pause 3/6/2017
Celgene (CELG) To Present New Data From Clinical Trials On Oral OTEZLA (Apremilast) At American Academy of Dermatology Congress 3/3/2017
Amgen (AMGN) Release: BLINCYTO (blinatumomab) Significantly Improved Overall Survival In Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Compared To Chemotherapy 3/2/2017
Amgen (AMGN) Release: Phase III Head-To-Head Trial Showed KYPROLIS (Carfilzomib) Significantly Improved Overall Survival Compared To Velcade (Bortezomib) In Relapsed Or Refractory Multiple Myeloma Patients 2/28/2017
Mederi Therapeutics Inc. Release: Landmark Study: Meta-Analysis Of 28 Studies Shows Stretta Therapy For GERD Consistently And Significantly Improves Outcomes 2/27/2017
Ampio Pharmaceuticals, Inc. (AMPE) Receives Guidance From The FDA And Proposes A Path For Approval For Single-Injection Ampion For The Treatment Of Pain Due To Severe Osteoarthritis Of The Knee 2/27/2017
Real-World Data From Boehringer Ingelheim Show Lower Risk Of Stroke And Major Bleeding For Pradaxa (Dabigatran Etexilate Mesylate) Compared To Warfarin 2/24/2017
GlaxoSmithKline (GSK) Release: Positive Results For Relvar Ellipta Lung Function Study In Patients With Well-Controlled Asthma 2/23/2017
Viriom Reports Positive Findings In Phase IIb Study Of Elpida As Compared To Efavirenz In Combination With TDF/FTC At CROI 2017 2/17/2017
Theratechnologies (TH.TO) Announces Comparative PK Data On The Intramuscular And Intravenous Administration Of The Monoclonal Antibody And Long-Acting Investigational Antiretroviral Ibalizumab 2/16/2017
Sanaria Inc.'s PfSPZ-CVac Vaccine Achieves High Level Protection Against Malaria In Clinical Trial 2/16/2017
Cumberland Pharmaceuticals (CPIX) Release: Caldolor Pediatric Fever Study Published Supporting Its Efficacy, Safety And Pharmacokinetics 2/7/2017
AMAG (AMAG) Announces Positive Topline Results From Definitive Pharmacokinetic Study For Makena Subcutaneous Administration 2/2/2017
InSitu Biologics Release: Company Non-Opiate Painkiller, AnestaGel, Found Superior In Preclinical Tests 1/26/2017
scPharmaceuticals Release: Biopharma Announces Start Of SUBQ-HF NHLBI Study With Its Subcutaneous Furosemide Product 1/24/2017
Sorrento (SRNE) Subsidiary, Scilex, Announces Key Endpoints Met In The European Union Pivotal Bioequivalence Clinical Study For Its Lead Product, ZTlido 1/9/2017
Pfizer (PFE) Announces Positive Top-Line Results From The Comparative REFLECTIONS B538-02 Study For PF-06410293, A Potential Biosimilar To Humira1 (Adalimumab) 1/5/2017
Commercial Patient Data Confirms Success of EnteroMedics (ETRM)' vBloc Therapy In Combination With vBloc Achieve Program In Patients Struggling To Lose Weight 12/15/2016
Pfizer (PFE) And Astellas (ALPMY) Announce Top-Line Results From Phase 4 PLATO Trial Of XTANDI (Enzalutamide) Capsules In Patients With Metastatic Castration-Resistant Prostate Cancer 12/15/2016
Janssen R&D Release: Daratumumab (DARZALEX) Combination Therapy Showed Consistent Clinical Benefit For Previously-Treated Patients With Multiple Myeloma 12/6/2016
Novartis AG (NVS) Data Shows Treatment-Free Remission Rates Are Consistently Above 50% Regardless Of Reason For Switch To Tasigna From Gleevec 12/6/2016
CTI BioPharma Release: PERSIST-2 Phase 3 Study Of Pacritinib Versus Best Available Therapy Shows Encouraging Clinical Activity In High-Risk Patients With Advanced Myelofibrosis In Late-Breaking Session At American Society of Hematology Annual Meeting 12/6/2016
Eisai Inc. (ESALF.PK) Announces New Analyses And Data On Perampanel At American Epilepsy Society Meeting 12/6/2016
Boehringer Ingelheim Release: New Data Show High Adherence Rates With Pradaxa (Dabigatran Etexilate Mesylate) In NVAF Patients 12/5/2016
Sorrento (SRNE) Subsidiary, Scilex Announces Key Endpoints Met In Pivotal Bioequivalence Clinical Study For Its Lead Product, ZTlido 12/5/2016
Mallinckrodt (MNK) Release: Clinical Pharmacokinetic And Health Economic Data On OFIRMEV (Acetaminophen) Injection Presented At 15th Annual Pain Medicine Meeting Of ASRA 11/18/2016
New Analysis Of Novartis AG (NVS)' Entresto Data Shows Long-Term Benefits On Heart Failure Readmissions And Total Cardiovascular Deaths 11/16/2016
First Patient Enrolled In Mallinckrodt (MNK) Phase 4 Trial Of H.P. Acthar Gel For Lupus 11/15/2016
UCB, Inc. (UCBJF.PK) Release: The Lancet Publishes First Head-To-Head Study Of CIMZIA (Certolizumab Pegol) And Humira (Adalimumab) In Bio-Naïve Rheumatoid Arthritis Patients 11/15/2016
Eli Lilly (LLY) Release: Jardiance (Empagliflozin) Consistently Reduced The Risk Of Cardiovascular Death In Adults With Type 2 Diabetes Regardless Of The Type Of Cardiovascular Disease At Baseline 11/14/2016
First Patient Enrolled In Mallinckrodt (MNK) Phase 4 Trial Of H.P. Acthar Gel For Rheumatoid Arthritis 11/14/2016
Eli Lilly (LLY) Release: Baricitinib Demonstrates Early Response Compared To Placebo And Significant Improvement Compared To Adalimumab In Patient-Reported Outcomes 11/14/2016
Horizon Pharma (HZNP) Presents Data On KRYSTEXXA (Pegloticase) For The Management Of Refractory Chronic Gout At The 2016 ACR/ARHP Annual Meeting 11/14/2016
Janssen Biotech (JNJ) Release: Two Studies Reveal Differences In Real-World Treatment Patterns In Rheumatoid Arthritis Patients Taking REMICAD (infliximab) Compared To CT-P13 (infliximab biosimilar) 11/14/2016
Eli Lilly (LLY) Release: New Analyses Of Phase 3 Trials Show Improvements In Rheumatoid Arthritis Symptoms Following Treatment With Baricitinib Across Diverse Population Of Patients 11/14/2016
Bayer (BAY) Release: 20+ Years Of Safety Data, Clinical Trials & Real-World Use Confirm Positive Benefit/Risk Profile Of ALEVE 11/14/2016
Bristol-Myers Squibb (BMY) Showcases Rheumatoid Arthritis And Immunoscience Commitment With Depth Of Research At 2016 American College of Rheumatology And Association Of Rheumatology Health Professionals Annual Meeting 11/14/2016
Sunovion Announces Positive Clinical Study Results For Latuda (Lurasidone HCL) In Adolescents With Schizophrenia 10/27/2016
Imprimis (immy)' Dropless Therapy Shows Significant Advantages In A Large Peer-Reviewed Study 10/25/2016
Janssen Pharmaceutical Release: Two New Real-World Studies Confirm Positive Efficacy And Safety Profile Of XARELTO (Rivaroxaban) In Treating And Preventing Blood Clots 10/24/2016
Boehringer Ingelheim Release: New Real-World Data Show Pradaxa (Dabigatran Etexilate Mesylate) Treatment Resulted In Less Use Of All-Cause Healthcare Resources Than Warfarin Treatment 10/21/2016
Takeda (TKPYY)'s Vedolizumab Demonstrated Robust Clinical Effectiveness And Safety In Inflammatory Bowel Disease In More Than 50 Real-World Studies 10/17/2016
Amgen (AMGN) Release: New Retrospective Analyses Confirm Vectibix (Panitumumab) Treatment Provided Survival Benefit Over Chemotherapy With Or Without Bevacizumab In Metastatic Colorectal Cancer Patients With Tumors Of Left-Sided Origin 10/10/2016
Ampio Pharmaceuticals, Inc. (AMPE) Announces Accepted Publication Of The Clinical Trial Results Of Its Oral Drug, Optina, Treatment Of Diabetic Macular Edema 10/4/2016
PTC Therapeutics (PTCT) Release: New Research Validates Translarna's (Ataluren) Mechanism Of Action To Promote Readthrough Of Nonsense Mutations And Produce Full-Length Functional Protein 10/4/2016
AstraZeneca PLC (AZN) Suffers Another Blow After Blood-Thinning Drug Flunks Trial 10/4/2016
Novartis AG (NVS) Late-Breaking Data Show Cosentyx Continues To Deliver High Skin Clearance For Majority Of Psoriasis Patients At Four Years 10/3/2016
Takeda Pharmaceutical Co. Ltd. (TKPYY) Release: Additional Interim Data Supporting Long-Term Use Of Vedolizumab In Patients With Ulcerative Colitis And Crohn's Disease Published In Journal Of Crohn's And Colitis 9/29/2016
Lubricin Release: Data Demonstrates Significant Improvement In Multiple Signs And Symptoms Of Dry Eye Disease Compared To Sodium Hyaluronate 9/20/2016
Important New Analysis Shows That Novartis Pharmaceutical Corporation (NVS)' Entresto Is Associated With Higher Relative Health-Related Quality Of Life Scores Among HFrEF Patients 9/19/2016
Roche (RHHBY) Says New MS Drug Works Better Than Merck & Co. (MRK)'s Rebif 9/19/2016
DelMar Pharma Presents Data Supporting The Potential Of VAL-083 As A New Treatment For Ovarian Cancer At The 11th Biennial Ovarian Cancer Research Symposium 9/13/2016
vBloc Institute Demonstrates Positive Clinical Success In Patients Struggling With Weight Loss As Compared To Pivotal FDA Trial With EnteroMedics (ETRM) VBloc Therapy In Combination With VBloc Achieve Program 9/13/2016
Egalet Announces OXAYDO Demonstrates Bioequivalence At 15 Mg Dose 9/12/2016
Kaleo Presents Studies At PAINWeek 2016 Comparing Naloxone Intramuscular Injection And Naloxone Intranasal Administration 9/8/2016
Raptor (RPTP) Presents Results From Meta-Analysis Demonstrating Efficacy Of QUINSAIR Comparable To Other Approved, Inhaled Antibiotics In Cystic Fibrosis Patients 9/7/2016
Boehringer Ingelheim Relelase: New Long-Term Data Demonstrates Continued Safety And Beneficial Effect Of Ofev (Nintedanib) For Patients With IPF 9/7/2016
Boehringer Ingelheim Release: New Long-Term Data Demonstrates Continued Safety And Beneficial Effect Of OFEV (Nintedanib) For Patients With IPF 9/7/2016
Boehringer Ingelheim Release: Tiotropium RESPIMAT Improved Lung Function With Safety Comparable To Placebo In Children With Asthma 9/6/2016
Vectura (VEC.L) Release: New Findings Confirm Ultibro Breezhaler Consistently More Effective Than Seretide In Reducing COPD Flare-Ups Across Different Patient Groups 9/6/2016
AstraZeneca PLC (AZN)'s Long-Acting Asthma Drug Symbicort Safe in Two Trials 9/1/2016
Seqirus Presents Analysis Reinforcing The Safety And Immunogenicity Profiles Of Its MF59-Adjuvanted Seasonal Trivalent Influenza Vaccine In Adults 65 Years And Older 8/29/2016
Amgen (AMGN) Announces Positive Top-Line Results From Phase 3 Study Of Prolia (Denosumab) In Patients Receiving Glucocorticoid Therapy 8/29/2016
Amgen (AMGN) Release: New Repatha (evolocumab) Analyses Show Efficacy And Safety Across Risk Groups In Results Presented At European Society of Cardiology Congress 2016 8/29/2016
Merck & Co. (MRK)'s Keytruda May Have an Edge Over Bristol-Myers Squibb (BMY)'s Opdivo for Cancer Doctors 8/26/2016
Armetheon Announces Positive Results Of Pharmacokinetics Study Of Tecarfarin Versus Warfarin 8/25/2016
Sunovion Pharmaceuticals Inc. Announces Publication Of Data Evaluating Dose Escalation Of Latuda (Lurasidone HCL) In The Treatment Of Schizophrenia 8/8/2016
Novo Nordisk A/S (NVO)'s Blockbuster Diabetes Med Victoza Does Not Help Severe Heart Failure 8/4/2016
Imprimis (immy) Release: Peer-Reviewed Study Of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared To Drops 7/22/2016
Amgen (AMGN) And Allergan (AGN) Biosimilar Found as Effective as Genentech (RHHBY)'s Herceptin 7/21/2016
Pfizer (PFE) Receives WHO Prequalification For Multi-Dose Vial Presentation Of Prevenar 13 7/19/2016
Mallinckrodt (MNK) Warned Over Missing Study About Child Opioids Use 7/8/2016
FDA Panel Narrowly Backs Cardiovascular Claims for Boehringer Ingelheim, Eli Lilly (LLY)'s Jardiance 6/29/2016
Boehringer Ingelheim Pharmaceuticals, Inc. Release: New Analysis Of INPULSIS Trials Demonstrates Efficacy Of OFEV (Nintedanib) Across A Range Of IPF Patients Using Broader Diagnostic Criteria 6/27/2016
Roche (RHHBY) CEO 'Sleeping Much Better' Following Positive News About Three New Drugs 6/23/2016
FDA Bestows Incyte (INCY)'s Ruxolitinib with Breakthrough Tag for Graft-Versus-Host Disease 6/23/2016
Kowa Pharmaceuticals America Release: New Data Demonstrate Pitavastatin More Effective Than Pravastatin In Improving Inflammatory And Immune Activation Markers In HIV-Infected Patients 6/21/2016
Pernix (PTX) Announces Positive Phase IV Results Of Silenor Vs. Zolpidem Head-To-Head Arousability Study 6/16/2016
Merck & Co. (MRK) Release: Systematic Review Of 58 Publications Of Real-World Use Of GARDASIL Presented At EUROGIN Congress 6/16/2016
Novo Nordisk A/S (NVO) Investors Disappointed as Top Selling Drug Victoza Didn't Do as Well as Expected 6/14/2016
Boehringer Ingelheim And Eli Lilly (LLY) Release: Jardiance (Empagliflozin) Significantly Reduced The Risk Of Progressive Kidney Disease In Adults With Type 2 Diabetes With Established Cardiovascular Disease 6/14/2016
Boehringer Ingelheim And Eli Lilly (LLY) Release: New Study Results Show Trajenta (Linagliptin) Reduces Blood Sugar In Adults With Type 2 Diabetes At Risk For Kidney Impairment 6/13/2016
AstraZeneca PLC (AZN) Presents New Data From Multiple Studies On The Effect Of BYDUREON On Glucose Fluctuations In Patients With Type 2 Diabetes 6/13/2016
New Data Presented At The Annual European Congress Of Rheumatology (EULAR 2016) Demonstrate Safety And Efficacy Of Biogen (BIIB)’s Anti-TNF Biosimilars Portfolio 6/9/2016
AstraZeneca PLC (AZN) To Highlight Scientific Advancements Across Its Diabetes Portfolio At The American Diabetes Association 76th Scientific Sessions 6/8/2016
ASCO2016: Caris Life Sciences Introduces Research Showing Time-To-Next Treatment As Effective Surrogate Outcome Measure In Retrospective Study Of 4729 Cancer Patients Undergoing Panomic Profiling 6/7/2016
ASCO2016: CTI BioPharma Long-Term Follow Up Data For Pacritinib Presented At 2016 ASCO Annual Meeting 6/7/2016
ASCO2016: Novartis Pharmaceuticals Corporation (NVS) Combination Therapy Tafinlar + Mekinist Demonstrates Overall Survival Benefit At Three-Year Follow-Up In Patients With Advanced Melanoma 6/7/2016
Array BioPharma (ARRY) Release: Encorafenib-Based Regimens Provide Improved PFS And OS In Difficult-To-Treat BRAF-Mutant Colorectal Cancer Compared To Historical Benchmarks 6/6/2016
ASCO2016: Celgene (CELG) Release: Data Presented At ASCO 2016 Builds Upon Foundation Of Abraxane Plus Gemcitabine As A First-Line Treatment In Patients With Metastatic Pancreatic Cancer 6/6/2016
Novartis Pharmaceuticals Corporation (NVS) Data Show Gilenya Had Significantly Greater Patient Retention Compared To iDMTs In Relapsing-Remitting MS 6/3/2016
Endo International (ENDP) Release: New Data Demonstrate Safety Of Long-Term, Around-The-Clock Treatment With BELBUCA (Buprenorphine) Buccal Film For Chronic Pain 6/3/2016
Study Published In Science Translational Medicine Reports Favorable Safety And Extended Survival For Brain Cancer Patients Treated With Tocagen Inc.'s Cancer-Selective Viral Gene Therapy 6/2/2016
Galderma Laboratories Announces Positive Results From The “Commplete” Regimen Study Including Epiduo Gel In The Management Of Acne In Adolescent Student Athletes 5/24/2016
After Initial Miss, GlaxoSmithKline (GSK)'s Pioneering Lung Study Shows Positive Results 5/24/2016
Relypsa (RLYP) Release: Data From New Analyses Of Studies With Veltassa Presented At 53rd European Renal Association Congress 5/23/2016
Sunovion Pharmaceuticals Inc.Announces Publication Of Data Evaluating The Long-Term Safety And Tolerability Of Latuda (Lurasidone Hcl) In The Treatment Of Bipolar Depression 5/23/2016
STELVIO Trial Shows Sustained Benefits For Emphysema Patients One Year After Treatment With Pulmonx, Inc.'s Zephyr Endobronchial Valves 5/19/2016
First Patient Enrolled In Mallinckrodt (MNK) Phase 4 Trial Of H.P. Acthar Gel For Rare Cause Of Nephrotic Syndrome 5/18/2016
BioPharmX Presents At American Congress Of Obstetricians And Gynecologists (ACOG) Suggesting Molecular Iodine May Be Effective, Non-Hormonal Treatment For FBC 5/16/2016
Sunovion Pharmaceuticals Inc. Announces Health Outcomes Data On Exacerbation-Related Hospitalizations That Support The Use Of Brovana (Arformoterol Tartrate) Inhalation Solution In People With Moderate-To-Severe COPD At The 2016 American Thoracic Society Conference 5/16/2016
Egalet Human Abuse Potential Data At American Pain Society Annual Meeting Demonstrates Significantly Lower Intranasal Abuse Potential Of ARYMO ER Compared To MS Contin 5/12/2016
Alimera Sciences (ALIM)' ILUVIEN Data Presented At 2016 Association for Research in Vision & Ophthalmology 5/6/2016
Starpharma Release: VivaGel Active Against Zika Virus 5/5/2016
Biogen (BIIB) R&D Spending Dropped 19% from Last Quarter 4/22/2016
Eli Lilly (LLY) Release: Jardiance (Empagliflozin) To Be Studied For The Treatment Of People With Chronic Heart Failure 4/19/2016
Bristol-Myers Squibb (BMY) Release: First Presentation Of Overall Survival Data For Opdivo (Nivolumab) Shows Significant Survival Benefit At One-Year Versus Investigator’s Choice In Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck 4/19/2016
Immune Pharma Release: New Biomarker Data To Be Presented At AACR Helps Predict Overall Survival In Patients With Acute Myeloid Leukemia (AML) Treated With Ceplene And Low-Dose IL-2 Immunotherapy, Including Those Over 60 Years Of Age 4/19/2016
Janssen Release: New Data From U.S. Post-Approval Study Assess Ischemic Stroke And Intracranial Hemorrhage Rates In People With Non-Valvular Atrial Fibrillation Comparing Both Rivaroxaban With Warfarin And Apixaban With Warfarin 4/18/2016
New Data Suggesting Positive Effects Of Sanofi Genzyme (SNY)’s Lemtrada (Alemtuzumab) On Brain Volume Loss And Retinal Nerve Fibers To Be Presented At American Academy of Neurology 4/18/2016
Janssen Release: Real-World Study Further Confirms Safety Profile Of XARELTO In Nearly 45,000 People With Non-Valvular Atrial Fibrillation (NVAF), Including Those With Concomitant Diabetes 4/4/2016
Novo Nordisk A/S (NVO) Release: Victoza (liraglutide [rDNA origin] injection) Provided Superior Hba1c Reductions In Adults With Type 2 Diabetes Compared To Continued Sitagliptin Treatment 4/4/2016
Health Canada Approves BioPharmX Study Of Violet Iodine 4/4/2016
Cardiome Pharma Corp. (COM.TO) Announces Publication Of Independent Study Comparing BRINAVESS To Ibutilide In Patients With Recent-Onset Atrial Fibrillation 3/31/2016
Specialised Therapeutics Asia Release: Novel Multiple Myeloma Drug Aplidin Shows Positive Results In Pivotal Phase 3 Study 3/31/2016
AstraZeneca PLC (AZN) Release: BRILINTA Preferred Over Clopidogrel In Updated American College of Cardiology And AHA Guideline In Acute Coronary Syndrome 3/31/2016
Janssen Research & Development Release: First Phase 3 Trial Of Daratumumab In Combination With Standard Therapy In Relapsed/Refractory Multiple Myeloma Meets Primary Endpoint In Planned Interim Analysis 3/30/2016
Boehringer Ingelheim Launches RE-COVERY DVT/PE: Global Observational Study On Management Of Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) With Pradaxa (Dabigatran Etexilate) 3/23/2016
AstraZeneca PLC (AZN)'s Brilinta Fails to Hit Main Goal of Stroke Study 3/23/2016
BioPharmX Initiates Post-Market Phase IV Study For Fibrocystic Breast Condition (FBC) And Cyclic Mastalgia 3/22/2016
SoCal's Aerie (AERI) Reports Positive Safety Data for Rhopressa 3/18/2016
Gilead (GILD) Shuts Down Six Zydelig Trials Following European Medicines Agency Review 3/17/2016
Viralytics Ltd (VLA.AX) Release: Positive CAVATAK Clinical Data Presented At 2016 European Association Of Urology Congress 3/15/2016
Janssen Pharmaceuticals, Inc. Release: First Real-World Evidence Comparing An SGLT2 Inhibitor With DPP-4 Inhibitors Shows Adults With Type 2 Diabetes Achieve Greater Blood Glucose Control With INVOKANA (canagliflozin) 3/14/2016
Boehringer Ingelheim Release: New Analyses: Adding SPIRIVA RESPIMAT Effective For Uncontrolled Asthma - Regardless Of Allergy Subtype 3/8/2016
New Novartis AG (NVS) Data Show Cosentyx Demonstrated Sustained Superiority In Skin Clearance (PASI 90) Versus Stelara At Week 52 3/7/2016
Celgene (CELG) Release: Oral OTEZLA (Apremilast) Long-Term Safety Data Presented At American Academy of Dermatology Congress 3/7/2016
AstraZeneca PLC (AZN), Novo Nordisk A/S (NVO) Investors Pin Hopes on Data from Two Closely-Watched Trials 3/2/2016
AEterna Zentaris (AEZS) Reports On Zoptrex Development Progress In China 3/1/2016
Arizona Pharmaceuticals Release: New Analysis Re-Affirms IR-Niacin As Evidence-Based Therapy For Dyslipidemia 3/1/2016
Female Libido Drug that Valeant (VRX) Bought for $1 Billion Gets Mixed Reviews 3/1/2016
Boehringer Ingelheim Release: New Analysis Confirms OFEV® (Nintedanib) Slows Disease Progression In IPF And Reduces Risk Of Acute Exacerbations 2/25/2016
ChromaDex, Inc. Announces Commencement Of An Obesity-Related Clinical Study Of NIAGEN In Collaboration With The University of Copenhagen And Aarhus University 2/22/2016
Amgen (AMGN)'s Aranesp Meets Primary Goal in Late Stage Trial 2/16/2016
Cumberland Pharmaceuticals (CPIX) Release: Vaprisol Dose Comparison Published Supporting Its Efficacy, Safety And Pharmacokinetics 2/10/2016
Boehringer Ingelheim Pharmaceuticals, Inc. Release: Newly Published Head-to-Head Data Show STIOLTO RESPIMAT Improved Lung Function Across Range Of Measures 2/9/2016
EPIRUS Biopharmaceuticals Initiates Pivotal Global Phase III Clinical Study For BOW015 (Infliximab Biosimilar) 2/9/2016
Valeant (VRX) Accused of Hiding Cold Drug Study Results Proving Drug Was No More Effective than a Placebo 2/3/2016
Journal of Clinical Oncology Publishes Results From The STRIVE Trial Of enzalutamide Compared To bicalutamide In Castration-Resistant Prostate Cancer 1/27/2016
First U.S. Patient Treated Following FDA Approval Of Cook Medical’s Zenith Alpha Thoracic Endovascular Graft 1/26/2016
Omeros Corporation (OMER) Release: Disclosure Of Omidria Post-Launch Study Findings To Occur At Hawaiian Eye And Retina Conference 1/18/2016
Hi-Tech Pharmaceuticals Announces OTC Nationwide Launch Of New Diet Pill -- Ionamin -- Backed By Clinical Study 1/12/2016
Regeneron (REGN) Investors Get Jitters From False Praluent Data 1/8/2016
ImaginAb, Inc.'s PSMA Imaging Agent Detects More Lesions Compared To Standard Imaging Methods For Detection Of Prostate Cancer In Phase I/Ila Study 1/6/2016
Teva (TEVA), Active Biotech (BTPC) Stop Higher Doses of Laquinimod in Two Multiple Sclerosis Trials 1/4/2016
Primary Endpoint Met in Baxalta (BXLT) and Momenta (MNTA)'s Biosimilar Study of Humira 12/22/2015
FDA Grants Fast Track Designation For MediciNova, Inc.'s MN-166 (Ibudilast) For The Treatment Of Amyotrophic Lateral Sclerosis 12/16/2015
Collegium (COLL) Announces Publication Of Nasal Human Abuse Potential Study In American Academy Of Pain Medicine 12/16/2015
Zydelig Study May Finally Transform Gilead (GILD) into a Cancer Powerhouse 12/11/2015
Defective Device Forces Regulators to Take a Hard Look at Bayer (BAY)'s Xarelto Trial 12/9/2015
Merck & Co. (MRK) Release: Findings Across A Range Of Hematological Cancers Add To The Growing Breadth Of KEYTRUDA (Pembrolizumab) Data 12/8/2015
Janssen Pharmaceutical Release: Real-World Data Confirms Safety And Efficacy Profile Of XARELTO, With Shorter Hospital Stays, For The Treatment Of Deep Vein Thrombosis 12/8/2015
ContraVir Reports Key CMX157 Data At HEP DART 2015 Demonstrating Enhanced In Vitro Safety Profile Compared To Viread 12/8/2015
Merck & Co. (MRK) Release: Findings Across A Range Of Hematological Cancers Add To The Growing Breadth Of KEYTRUDA (Pembrolizumab) Data 12/8/2015
SteadyMed (STDY) Demonstrates Potential For Reduced Infusion Site Sensitivity Associated With Trevyent Compared To Remodulin 12/7/2015
AbbVie (ABBV) Release: IMBRUVICA (Ibrutinib) Phase 3 RAY Data Show Significant Reductions In Disease Progression Versus Temsirolimus In Relapsed/Refractory Mantle Cell Lymphoma Patients 12/7/2015
Researchers Find Additional Benefits of Novartis AG (NVS)'s Heart Failure Drug Entresto 12/3/2015
H. Lundbeck A/S (LUN.CO) Release: Largest Prospective Study Evaluating The Effect Of Vigabatrin On Vision 11/25/2015
BioMarin (BMRN) Stocks Drop After FDA Panel is Critical of DMD Treatment Drisapersen 11/23/2015